- Location
NSAIDs
"-
Zimmer Issues Five New Patents Directed to The Subchondroplasty Procedure
Feb 26, 2014Zimmer Holdings has announced that the US Patent and Trademark Office has issued five new patents directed to the Subchondroplasty procedure, the innovative new joint preservation procedure developed by Zimmer Knee Creations: US Patent No. ...
Tags: Zimmer Holdings, Medicine
-
Naproxen Is Safer for The Heart Than Other Popular Anti-inflammatory Drugs
Feb 25, 2014TUESDAY Feb. 10, 2014, 2014 -- The science isn't convincing enough to say that naproxen -- the key pain reliever in Aleve -- is safer for the heart than other popular anti-inflammatory drugs such as ibuprofen (Advil and Motrin), U.S. health ...
-
Vireo Systems Has Unveiled New Packaging and Design for Its Flagship Product AminoActiv
Feb 19, 2014US-based health care products manufacturer Vireo Systems has unveiled new packaging and design for its flagship product AminoActiv, a non-toxic pain reliever. The new labeling and packaging formats have been designed to increase ...
Tags: care products, health products
-
NSAIDs Before Vaccinating Horses to Reduce Risk and Severity of Such Reactions
Jan 23, 2014Although vaccination against infectious disease is a routine component of horse care, many owners still voice concerns about their horse's risk of having an adverse reaction to these injections. For this reason, veterinarians sometimes ...
-
ASA Released Its Second List of Five Targeted, Evidence-Based Recommendations
Jan 22, 2014Not prescribing opioids first or as a long-term therapy for chronic, non-cancer pain and avoiding MRIs, CTs and X-rays for low-back pain are among the tests and treatments identified by ASA that are commonly ordered but not always ...
-
U.S. Food and Drug Administration (FDA) Has Accepted for Review The SNDA
Jan 16, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
Tags: Iroko Pharmaceuticals, FDA, ZORVOLEX, osteoarthritis pain
-
FDA Has Accepted for Review The Supplemental New Drug Application
Jan 15, 2014Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug Application ...
-
If You Need to Use a Laxative, FDA Warns That Some Products Can Be Dangerous
Jan 9, 2014If you are constipated and need to use a laxative, the U.S. Food and Drug Administration wants you to know that some products can be dangerous if you don't follow the dosing instructions or you have certain medical conditions. The agency ...
-
New Device for Medication Deliveryis Developed by Alsa Refinish
Dec 23, 2013Alsa Refinish, a California-based company, has process and utility patent applications in place for a medication delivery method. If successful, Alsa will hold patents for a device that delivers medications and herbal preparations ...
Tags: Alsa Refinish, Medication Delivery
-
Iroko Has Entered Into a $75m Debt Facility Agreement with an Affiliate of OrbiMed
Nov 22, 2013US-based Iroko Pharmaceuticals has entered into a $75m debt facility agreement with an affiliate of OrbiMed Advisors (OrbiMed) to support general business operations and the launch of Zorvolex (diclofenac). Zorvolex is the first and only ...
-
The US FDA Has Approved Antares Pharma's OTREXUP
Oct 16, 2013The US Food and Drug Administration (FDA) has approved Antares Pharma's (Antares) OTREXUP, a single-dose, disposable auto-injector for the subcutaneous (SC) once-weekly administration of methotrexate (MTX). OTREXUP is reportedly the first ...
-
Imprimis Pharmaceuticals Has Received Approval From The Institutional Review Board
Jul 26, 2013Imprimis Pharmaceuticals has received approval from the Institutional Review Board (IRB) to initiate Phase III clinical trial protocol of its new topical non-steroidal anti-inflammatory drug (NSAID) candidate, Impracor. Impracor is based ...
-
You Can Take a Daily Aspirin & Acetaminophen Related Drugs at The Same Time
May 30, 2013Yes. Acetaminophen (Tylenol and generic) is actually a better choice than Advil, Motrin, or related drugs for people who take a daily aspirin but need relief for minor aches and pains. While a daily low-dose aspirin can slash the risk of ...
-
Iroko Pharmaceuticals Has Launched a New Corporate Headquarters in US
Dec 14, 2012Iroko Pharmaceuticals has launched a new corporate headquarters in Philadelphia's Navy Yard Corporate Center, US. The new facility will support increased workforce as the company moves ahead with five late-stage development programs to ...
Tags: drug candidates, drugs, NSAIDs, medications
Related Products
-
Non-Woven Fabric Without Ethylene Oxide Sterilization Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sodium Hyaluronate Gel
-
Two Years Singjoint Prefilled Syringe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Gel for Adult
-
Without Ethylene Oxide Sterilization Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hyaluronic Acid
-
Without Ethylene Oxide Sterilization Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Sodium Hyaluronate Gel
-
Non-Woven Fabric Surgical Supplies Materials Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hyaluronic Acid Injection
-
Two Years Non-Woven Fabric Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Hyaluronic Acid
